Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Celularity (CELU).
Celularity Inc. has announced the appointment of Richard J. Berman as a Class II director, filling a vacancy created by the resignation of Robin L. Smith, M.D. Berman, considered independent according to Nasdaq’s standards, will also join the Audit Committee. He’s granted an option to buy 118,111 shares of Celularity’s stock, vesting over three years with continued service, and has entered into a standard indemnification agreement with the company. Additionally, following Marc Mazur’s departure, Celularity’s board will reduce from seven to six directors.
For a thorough assessment of CELU stock, go to TipRanks’ Stock Analysis page.